DE602005013745D1 - Verwendung einer flüchtigen, rhinologisch wirksamen Zusammensetzung auf faserigen Gewebe zur Erleichterung der nasalen Atmung - Google Patents

Verwendung einer flüchtigen, rhinologisch wirksamen Zusammensetzung auf faserigen Gewebe zur Erleichterung der nasalen Atmung

Info

Publication number
DE602005013745D1
DE602005013745D1 DE602005013745T DE602005013745T DE602005013745D1 DE 602005013745 D1 DE602005013745 D1 DE 602005013745D1 DE 602005013745 T DE602005013745 T DE 602005013745T DE 602005013745 T DE602005013745 T DE 602005013745T DE 602005013745 D1 DE602005013745 D1 DE 602005013745D1
Authority
DE
Germany
Prior art keywords
volatile
fibrous tissue
active composition
nasal breathing
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005013745T
Other languages
English (en)
Inventor
Joerg Kleinwaechter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of DE602005013745D1 publication Critical patent/DE602005013745D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Paper (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
DE602005013745T 2005-02-28 2005-02-28 Verwendung einer flüchtigen, rhinologisch wirksamen Zusammensetzung auf faserigen Gewebe zur Erleichterung der nasalen Atmung Active DE602005013745D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05004303A EP1698331B1 (de) 2005-02-28 2005-02-28 Verwendung einer flüchtigen, rhinologisch wirksamen Zusammensetzung auf faserigen Gewebe zur Erleichterung der nasalen Atmung

Publications (1)

Publication Number Publication Date
DE602005013745D1 true DE602005013745D1 (de) 2009-05-20

Family

ID=34933972

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005013745T Active DE602005013745D1 (de) 2005-02-28 2005-02-28 Verwendung einer flüchtigen, rhinologisch wirksamen Zusammensetzung auf faserigen Gewebe zur Erleichterung der nasalen Atmung

Country Status (7)

Country Link
EP (1) EP1698331B1 (de)
AT (1) ATE427744T1 (de)
AU (1) AU2005328317B2 (de)
CA (1) CA2599614C (de)
DE (1) DE602005013745D1 (de)
MX (1) MX2007010476A (de)
WO (1) WO2006093537A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1987196A2 (de) * 2006-02-22 2008-11-05 The Procter and Gamble Company Faserstrukturen mit flüchtigen wirkstoffen
CA2695990C (en) 2007-08-10 2018-01-02 Little Busy Bodies, Inc. Saline nose wipe and methods of manufacture and use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB672254A (en) * 1949-05-24 1952-05-21 Griffiths Hughes Ltd E Improvements in or relating to pocket inhalers
US3818533A (en) * 1969-07-18 1974-06-25 Alustikin Prod Inc Treated paper and non-woven material for wiping surfaces and method therefor
US5275859A (en) * 1992-12-21 1994-01-04 Eastman Kodak Company Tobacco smoke filter
US5607754A (en) * 1993-11-12 1997-03-04 Kimberly-Clark Corporation Paper web product and method for manufacturing same
US5830487A (en) * 1996-06-05 1998-11-03 The Procter & Gamble Company Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products
US6238682B1 (en) * 1993-12-13 2001-05-29 The Procter & Gamble Company Anhydrous skin lotions having antimicrobial components for application to tissue paper products which mitigate the potential for skin irritation
KR100373792B1 (ko) * 1994-12-19 2003-04-21 더 프록터 앤드 갬블 캄파니 약물처리된티슈페이퍼제품
AU724588B2 (en) * 1997-04-09 2000-09-28 Kao Corporation Skin cleansing sheet
US6602387B1 (en) * 1999-11-26 2003-08-05 The Procter & Gamble Company Thick and smooth multi-ply tissue
DE10058459A1 (de) * 2000-11-24 2002-06-06 Haarmann & Reimer Gmbh Rhinologica
JP4342761B2 (ja) * 2001-04-17 2009-10-14 花王株式会社 殺菌剤組成物
DE10246836A1 (de) * 2002-10-08 2004-04-22 Saxol Chemie Gmbh Wasserfreie oder wasserhaltige Zusammensetzung zur Behandlung eines hydrophilen Papierprodukts

Also Published As

Publication number Publication date
AU2005328317A1 (en) 2006-09-08
EP1698331B1 (de) 2009-04-08
ATE427744T1 (de) 2009-04-15
CA2599614A1 (en) 2006-09-08
WO2006093537A1 (en) 2006-09-08
CA2599614C (en) 2012-07-03
MX2007010476A (es) 2007-10-15
AU2005328317B2 (en) 2009-09-10
EP1698331A1 (de) 2006-09-06

Similar Documents

Publication Publication Date Title
MY159562A (en) Adipose tissue derived stromal cells for the treatment of neurological disorders
MY176938A (en) 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d] pyrimidin-2-one compounds and prodrugs thereof
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
WO2008060610A3 (en) Systemic administration of colony stimulating factors to treat amyloid associated disorders
WO2006017566A3 (en) Modulation of bio-electrical rhythms via a novel engineering approach
AR054249A1 (es) Tratamiento de enfermedades del tejido conectivo de la piel
Oh et al. Effects of aroma gargling, cold water gargling, and wet gauze application on thirst, halitosis, and sore throat of patients after spine surgery
FR2887766B1 (fr) Composition cosmetique comprenant des elastomeres
AR059864A1 (es) Compuesto de benzamida composicion farmaceutica que lo comprende su uso para preparar un medicamento y procedimientos para su preparacion
SE0102147D0 (sv) New methods
DE602005013745D1 (de) Verwendung einer flüchtigen, rhinologisch wirksamen Zusammensetzung auf faserigen Gewebe zur Erleichterung der nasalen Atmung
WO2007025229A3 (en) Compositions and their uses directed to hsp27
NZ597657A (en) Use sulphur particles less than 300 microns and sodium lignin sulfonate for treating diseases casused by microbial pathogenic infections
BRPI0500101A (pt) Composições bifásicas contendo álcool
MY158799A (en) New medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts
DE60228988D1 (de) Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen
DE602004021915D1 (de) Verwendung der cinchonapflanze zur herstellung eines medikamentes zur stimulierung der angiogenese
CA2599590A1 (en) Use of a volatile cooling sensate on fibrous tissues to provide a sensation of rhinological decongestion
WO2013098519A3 (fr) Utilisation d'une composition pour prevenir et lutter contre les effets du tabac sur la peau
DE502004011874D1 (de) Flupirtine-präparat zur behandlung von neurodegeneetes mellitus
KR200483673Y1 (ko) 지압구
DE602006019842D1 (de) Verwendung von lecithin als arzneimittel zur behandlung von psoriasis
KR20220073210A (ko) 패치가 포함된 마스크
CN201085732Y (zh) 麻醉手术用一次性眼部护贴
KR20080000297U (ko) 최적의 숙면을 위하여 아로마 테라피 기능을 첨가하도록고안된 경추형 목침베게

Legal Events

Date Code Title Description
8364 No opposition during term of opposition